| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |